Atlas Trials

Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL

Clinical trial NCT00185445 · COMPLETED

Trial details

NCT number
NCT00185445
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Hodgkin Lymphoma
Start date
2004-06-01
Primary completion
2006-10-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.